CALDAN THERAPEUTICS LIMITED
Company number SC515558 · Monitor this company
Overview
- Company type
- Private Limited Company
- Incorporated
- 2015-09-14
- Dissolved
- 2026-07-30
- Registered office
- 7 St James Terrace, Lochwinnoch Road, Kilmacolm, PA13 4HB
- Postcode
- PA13 4HB
- Capital
- 8 GBP
- Accounts category
- Full
- Charges
- 0 outstanding
Accounts
- Last made up to
- 2023-09-30
- Financial year end
- 30 September
Confirmation statement
- Last statement dated
- 2024-06-12
Nature of business (SIC)
- 72110 Research and experimental development on biotechnology
Officers 5 current · 6 resigned
Lori Krim, Dr GOUGH
Director
Mary Eugenie, Dr CANNING
Director
DR Mark Anthony, Dr PAYTON
Director
MR Graeme MILLIGAN
Director
MR Trond ULVEN
Director
Group structure
Controlled by EPIDAREX CAPITAL II, LP — since 2016-04-06
From persons-with-significant-control filings on the public register.
Contact details
- Website
- caldantherapeutics.co.uk
Caldan Therapeutics discovers novel therapeutics for metabolic diseases including Type 2 Diabetes and other indications including non-alcoholic steatohepatitis (NASH) and inflammatory diseases.
Previous registered addresses 1
| Address | Changed on |
|---|---|
| NO.11 THE SQUARE UNIVERSITY AVENUE, GLASGOW, G12 8QQ, UNITED KINGDOM | 2016-07-08 |
The class of 2015
39%
of the 363 companies in this sector incorporated in 2015 are still active today; 58% have since been dissolved.
A fact about the year, not a forecast for this company.